EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Metformin Suppresses Both PD-L1 Expression in Cancer Cells and Cancer-Induced PD-1 Expression in Immune Cells to Promote Antitumor Immunity

Su Hwan Park iD, Juheon Lee iD, Hye Jin Yun iD, Seok-Ho Kim iD, Jong-Ho Lee iD

Annals of Laboratory Medicine · 2024

DOI: 10.3343/alm.2023.0443 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Laboratory Medicine, 2024. Verfasst von Su Hwan Park und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Sciences, The Graduate School of Dong-A University, Busan, Korea. Hauptthemen laut MEDLINE: Metformin, Programmed Cell Death 1 Receptor, B7-H1 Antigen, Killer Cells, Natural. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Dong-A University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MetforminProgrammed Cell Death 1 ReceptorB7-H1 AntigenKiller Cells, Naturalbeta CateninHumansAnimalsCell Line, TumorMiceXenograft Model Antitumor AssaysAMP-Activated Protein KinasesMice, Inbred BALB CPhosphorylationMice, NudeT-LymphocytesProto-Oncogene Proteins c-aktNeoplasmsUbiquitination

Stichwörter der Autor:innen

E3 ligaseImmunotherapyMetforminPD-1PD-L1Tumor immune evasion

Substanzen

MetforminProgrammed Cell Death 1 ReceptorB7-H1 AntigenCD274 protein, humanPDCD1 protein, humanbeta CateninAMP-Activated Protein KinasesProto-Oncogene Proteins c-akt

Autor:innen und Institutionen

  • Department of Health Sciences, The Graduate School of Dong-A University, Busan, Korea.
  • Department of Medicinal Biotechnology, College of Health Science, Dong-A University, Busan, Korea.
  • Department of Biomedical Sciences, Dong-A University, Busan, Korea.

ORCID-Profile: Su Hwan Park, Juheon Lee, Hye Jin Yun, Seok-Ho Kim, Jong-Ho Lee

Förderung

  • Dong-A University

Zitieren

APA

Park, S. H., Lee, J., Yun, H. J., Kim, S. H., & Lee, J. H. (2024). Metformin Suppresses Both PD-L1 Expression in Cancer Cells and Cancer-Induced PD-1 Expression in Immune Cells to Promote Antitumor Immunity. Annals of Laboratory Medicine. https://doi.org/10.3343/alm.2023.0443

Vancouver

Park SH, Lee J, Yun HJ, Kim SH, Lee JH. Metformin Suppresses Both PD-L1 Expression in Cancer Cells and Cancer-Induced PD-1 Expression in Immune Cells to Promote Antitumor Immunity. Annals of Laboratory Medicine. 2024. doi:10.3343/alm.2023.0443

BibTeX
@article{Park2024,
  author = {Park, Su Hwan and Lee, Juheon and Yun, Hye Jin and Kim, Seok-Ho and Lee, Jong-Ho},
  title = {Metformin Suppresses Both PD-L1 Expression in Cancer Cells and Cancer-Induced PD-1 Expression in Immune Cells to Promote Antitumor Immunity},
  journal = {Annals of Laboratory Medicine},
  year = {2024},
  doi = {10.3343/alm.2023.0443}
}
Kostenlos starten →